
EDAN Showcases Advanced Medical Technology Innovations Across Imaging, Patient Monitoring and Diagnostics at MEDICA 2026
Edan Instruments, a global provider of medical devices and healthcare solutions, is presenting its latest medical technology innovations at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. Through its participation in the international medical technology exhibition, EDAN is highlighting developments across diagnostic imaging, patient monitoring, cardiology, obstetrics and gynecology (OBGYN), in vitro diagnostics (IVD) and veterinary healthcare.
MEDICA provides an important platform for medical technology companies, healthcare professionals, distributors and industry partners to exchange knowledge, explore emerging technologies and discuss the changing needs of healthcare systems. For EDAN, the exhibition offers an opportunity to demonstrate its expanding product portfolio, engage with European partners and strengthen relationships across the international healthcare market.
The company’s presence at the event reflects its continued focus on translating clinical insights into practical medical technologies. By developing solutions across multiple healthcare specialties, EDAN aims to support healthcare professionals with accessible and reliable equipment that can contribute to clinical assessment, diagnostic workflows, patient monitoring and treatment decisions.
“Germany and Europe are important partners in the global healthcare industry. As China’s medical technology sector expands internationally, closer collaboration with European healthcare professionals and industry partners can create opportunities for shared progress,” said Alex You, Senior Director of Marketing, Customer Service, Global Connectivity & Integration at EDAN. “By understanding local clinical needs and translating them into accessible, reliable solutions, we can contribute to more effective healthcare. MEDICA offers a valuable opportunity to strengthen these connections and exchange perspectives.”
At MEDICA 2026, EDAN is presenting a range of technologies designed to address clinical requirements across hospitals, diagnostic laboratories, outpatient facilities and veterinary practices. Among the highlights are the debut of the Acclarix LX9S ultrasound system, developments in the iV Series patient monitoring platform, connected ECG management solutions, an upcoming wearable Patch Holter and upgrades to its IVD product portfolio.
Acclarix LX9S makes its debut with advanced ultrasound imaging capabilities
One of the key highlights of EDAN’s exhibition is the introduction of the Acclarix LX9S ultrasound system, powered by the company’s SynSight zone sonography platform. The system is designed to deliver consistent image clarity across a variety of clinical scenarios, supporting healthcare professionals in conducting ultrasound examinations and evaluating diagnostic information.
Ultrasound imaging is widely used across different medical specialties because it allows clinicians to examine internal structures and assess a range of clinical conditions. Image quality, system responsiveness and workflow efficiency are important considerations in ultrasound equipment, particularly in clinical environments where healthcare professionals perform examinations across different patient populations and applications.
The Acclarix LX9S incorporates a new eSRI imaging algorithm intended to enhance imaging performance. The system also features a 23.8-inch display, an optical trackball and a redesigned touchscreen interface. These hardware and software updates are intended to improve the user experience while supporting image interpretation and routine examination workflows.
The larger display provides an expanded viewing area for ultrasound images and clinical information, while the optical trackball and redesigned touchscreen interface are intended to make system navigation more convenient. By bringing together imaging technology and interface improvements, EDAN aims to support clinicians in managing examinations more efficiently.
The SynSight zone sonography platform forms the technological foundation of the system, with the objective of maintaining image clarity across diverse clinical applications. The new eSRI algorithm adds another imaging enhancement to the platform, supporting the company’s efforts to advance its ultrasound portfolio.
Through the Acclarix LX9S, EDAN is demonstrating its approach to combining imaging performance, system design and workflow functionality in a single ultrasound solution. Its debut at MEDICA provides an opportunity for European healthcare professionals and industry partners to explore the system and understand its capabilities.
iV Series supports patient monitoring and critical-care workflows
Patient monitoring is another major area of EDAN’s participation at MEDICA 2026. The company highlighted the iV100, a versatile monitoring solution that can function as both a transport monitor and a multi-parameter module within the iV Series.
Patient monitoring plays an essential role in healthcare environments where clinicians need continuous information about a patient’s physiological condition. In critical-care units, operating rooms and patient transport settings, monitoring technologies help healthcare professionals observe changes in vital parameters and support clinical decision-making.
The iV100 is designed to provide flexibility across different care environments. Its dual functionality allows it to operate as a transport monitor while also serving as a multi-parameter module within the broader iV Series. This approach is intended to support continuity in patient monitoring as individuals move between different clinical settings.
A key feature highlighted by EDAN is real-time PresCCO continuous cardiac output monitoring. Continuous cardiac output information can provide clinicians with additional insight into cardiovascular function, particularly when caring for patients who require close hemodynamic assessment.
The iV Series also incorporates advanced parameters and clinical assistive applications designed to support monitoring and clinical workflows. By combining these capabilities, the platform aims to help healthcare professionals access relevant patient information and manage monitoring requirements across varied clinical environments.
EDAN’s presentation of the iV100 reflects the importance of flexible monitoring technologies in modern healthcare. Hospitals and other care facilities require equipment that can adapt to different clinical situations while supporting efficient workflows and reliable access to patient data.
Connected cardiology solutions and wearable ECG monitoring
In cardiology, EDAN is highlighting Smart ECG Web, a centralized platform designed to connect ECG devices across hospital departments and healthcare facilities. The solution supports ECG data management, review and reporting through a connected system.
Electrocardiography is a fundamental diagnostic tool used to assess the electrical activity of the heart. ECG examinations are conducted in a wide range of healthcare settings, including hospitals, outpatient clinics and specialist cardiology departments. As healthcare organizations manage increasing volumes of diagnostic information, connected platforms can help support the organization and accessibility of ECG records.
Smart ECG Web is designed to connect ECG devices across different departments and facilities, enabling centralized management of ECG information. Its functions include data review and reporting, supporting a more connected approach to clinical workflows.
By bringing ECG information together through a centralized platform, the solution is intended to help healthcare professionals access and review diagnostic records more efficiently. It also supports collaboration across departments and healthcare facilities by providing a common environment for managing ECG data.
In addition to its connected ECG platform, EDAN is preparing to introduce a wearable Patch Holter designed to provide up to 14 days of continuous ECG recording.
Traditional ECG examinations typically capture cardiac electrical activity during a relatively short assessment period. However, some heart rhythm abnormalities occur intermittently and may not be present during a routine examination. Longer-duration monitoring can help healthcare professionals collect additional information about cardiac activity over an extended period.
The wearable Patch Holter is intended to address this requirement by supporting continuous ECG recording for up to 14 days. The extended monitoring period may help capture intermittent cardiac events that could otherwise remain undetected during shorter examinations.
Wearable cardiac monitoring technologies are increasingly relevant to the evaluation of patients with symptoms that occur unpredictably or are difficult to capture during a brief clinical visit. By offering longer-duration recording, the Patch Holter is designed to provide clinicians with additional ECG information for patient assessment.
EDAN’s cardiology portfolio therefore combines centralized ECG data management with the development of wearable monitoring technology. Together, these solutions reflect the company’s focus on supporting connected diagnostic workflows and expanding options for cardiac assessment.
OBGYN portfolio addresses maternal and women’s healthcare
EDAN is also presenting its obstetrics and gynecology portfolio, which covers several areas of maternal and women’s healthcare. The company’s solutions include fetal and maternal monitoring, intrapartum imaging, endoscopy, colposcopy and pelvic floor rehabilitation.
These technologies are intended to support healthcare professionals across different stages of obstetric and gynecologic care. The portfolio addresses monitoring requirements during pregnancy and childbirth, as well as diagnostic and therapeutic needs associated with women’s reproductive and pelvic health.
Fetal and maternal monitoring systems play an important role in assessing the condition of both mother and fetus during pregnancy and labor. These technologies provide clinical information that healthcare professionals can use when evaluating maternal and fetal well-being and determining appropriate care.
Intrapartum imaging supports clinical assessment during labor and delivery, while endoscopy and colposcopy technologies provide tools for examining relevant anatomical structures and supporting gynecologic evaluation.
EDAN’s inclusion of pelvic floor rehabilitation further extends its portfolio into an area of women’s health focused on pelvic floor function and related care needs. By bringing together monitoring, imaging, endoscopic and rehabilitation technologies, the company aims to provide solutions for a broader range of obstetric and gynecologic settings.
The presentation of the OBGYN portfolio at MEDICA highlights EDAN’s approach to addressing specialty-specific clinical requirements through a range of medical devices and healthcare solutions.
IVD upgrades expand blood gas, chemistry and hematology testing capabilities
In vitro diagnostics is another important component of EDAN’s product showcase. The company is presenting updates to its i500 blood gas and chemistry analyzer, alongside its H90 Series six-part automated hematology analyzer.
The EDAN i500 combines full benchtop capabilities with a compact design, making it suitable for healthcare environments that require blood gas and chemistry testing while managing available laboratory space. Blood gas analysis is particularly important in critical-care settings, where clinicians may need timely information to assess a patient’s respiratory and metabolic status.
The latest i500 upgrade features a co-oximetry panel and automatic quality control (auto-QC) functionality. These additions are intended to expand the analyzer’s testing capabilities and support laboratory quality processes.
Co-oximetry provides additional information about hemoglobin-related measurements, which can be relevant in clinical assessments involving oxygen transport and blood composition. The addition of a co-oximetry panel expands the information available through the analyzer, supporting its use in critical-care environments.
The auto-QC functionality is designed to support quality control processes by automating aspects of routine quality checks. Quality control is an essential part of laboratory testing because it helps laboratories monitor analytical performance and maintain confidence in test results.
By combining benchtop capabilities, a compact configuration and these upgraded functions, EDAN aims to provide a practical testing solution for clinical environments where timely diagnostic information is important.
The company is also highlighting the H90 Series six-part automated hematology analyzer, which features reticulocyte (RET) detection. Hematology analyzers are used to evaluate blood samples and provide information about different blood cell populations. These results support the assessment and monitoring of a range of hematological conditions.
The six-part analysis capability expands the system’s ability to classify blood cell populations, while RET detection provides additional information about reticulocytes, which are immature red blood cells. Reticulocyte measurements can help clinicians assess aspects of red blood cell production and bone marrow response.
The H90 Series therefore adds another testing capability to EDAN’s IVD portfolio. Its presentation alongside the upgraded i500 demonstrates the company’s focus on supporting clinical laboratories and critical-care testing through a broader range of diagnostic instruments.
CC30 Vet expands EDAN’s presence in animal healthcare
Beyond human healthcare, EDAN is also presenting technologies designed for veterinary applications. The company’s CC30 Vet biochemistry analysis system is focused on assessing liver and kidney function in pets.
Veterinary diagnostic testing is an important part of evaluating animal health, identifying potential disease and monitoring the response to treatment. Biochemistry testing can provide information about organ function and help veterinary professionals assess the health status of companion animals.
The CC30 Vet system features a range of cartridges and testing parameters designed to support different screening requirements in veterinary practice. Its focus on liver and kidney function addresses two important areas of pet health assessment.
Liver and kidney-related measurements can provide useful information when veterinarians investigate symptoms, conduct routine health evaluations or monitor animals with known medical conditions. The availability of different cartridges and testing parameters is intended to give veterinary practices flexibility in selecting tests according to their clinical requirements.
With the CC30 Vet, EDAN is extending its diagnostic technology portfolio beyond hospitals and human healthcare facilities into animal health. The system reflects the company’s broader interest in developing practical diagnostic solutions for different healthcare environments and patient populations, including companion animals.
Strengthening international collaboration through MEDICA 2026
EDAN’s participation in MEDICA 2026 provides a platform to demonstrate its expanding portfolio while engaging with European healthcare professionals, distributors and industry partners. The company’s presence reflects the importance of international collaboration as medical technology providers respond to changing clinical needs and healthcare delivery requirements.
The exhibition brings together products and technologies across multiple medical specialties, allowing EDAN to present its developments in ultrasound imaging, patient monitoring, cardiology, OBGYN, IVD and veterinary diagnostics.
The company’s approach emphasizes the connection between clinical requirements and product development. By engaging with healthcare professionals and industry partners, EDAN aims to better understand local needs and translate those insights into accessible and reliable solutions.
The leadership statement from Alex You reinforces the importance of collaboration with European partners as China’s medical technology sector continues its international expansion. Through dialogue and exchange at events such as MEDICA, the company seeks to strengthen relationships and identify opportunities for shared progress in healthcare.
Across its diverse medical portfolios, EDAN continues to focus on turning clinical insights into practical solutions. Its latest showcase demonstrates efforts to advance imaging performance, improve monitoring flexibility, support connected cardiology workflows, expand laboratory testing capabilities and address diagnostic requirements in veterinary practice.
As MEDICA 2026 brings together participants from across the global healthcare industry, EDAN is using the event to highlight its latest innovations and reinforce its commitment to developing medical technologies that address real clinical needs and contribute to improving the human condition.



